Led by Secondcell Bio, the delegation of up to 150 U.S. BioTech owners and executives includes world-leading scientists, medical doctors, entrepreneurs, intellectual property experts, and senior business, finance, and legal teams.
The purpose of Secondcell Bio's visit is to close a joint venture biotechnology partnership to discover and commercialize jointly owned new BioTech and medical innovations. The delegation will take place on the occasion of the UAE BioTech Symposium in partnership with AmCham Abu Dhabi BioTech Committee and Masdar City. ABU DHABI , UAE , Sept.
24, 2024 /PRNewswire/ -- U.S. BioTech firm Secondcell Bio is organizing its first delegation to Abu Dhabi for 20+ senior team members and advisors.
As part of the UAE's national effort to catalyze its knowledge-based economy, the delegation will take business meetings to accelerate 2.5-year ongoing discussions towards the formation of a national level joint venture BioTech company to create and commercialize novel and jointly owned Made-in-Abu-Dhabi-BioTech-IP. Emirati leadership has captured the imagination of Dr.
Kambiz Shekdar , PhD, CEO of Secondcell Bio and his team regarding the new and rapidly growing BioTech and Life Sciences sector in the UAE, including the following directives by healthcare leaders in the UAE about how the country is revamping this sector, including thoughts on leadership, structure, mandate, and mission: UAE Genetic Disease Association Founder and Chairperson Her Excellency Dr. Marya.